Kenvue's Q4 Sales Miss, Margins Improve

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and Beauty segment.Consumer healthcare products specialist Kenvue (KVUE -0.05%) reported mixed fourth-quarter and full-year earnings on Thursday, Feb. 6. Adjusted earnings per share (EPS) of $0.26 aligned with the market's consensus expectations. Revenue came in at $3.66 billion, falling short of the $3.76 billion estimate and effectively flat when compared to Q4 2023. Despite some headwind ...